Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDermata Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$2.04 | $0 | |||
| 08/07/2024 | Q2 2024 | -$4.18 | $0 | |||
| 03/30/2024 | Q1 2024 | -$7.06 | $0 | |||
| 03/21/2024 | Q4 2023 | -$0.54 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.54 | $0 | |||
| 08/10/2023 | Q2 2023 | -$0.63 | $0 | |||
| 05/11/2023 | Q1 2023 | -$2.23 | $0 | |||
| 03/28/2023 | Q4 2022 | -$2.06 | $0 | |||
| 11/10/2022 | Q3 2022 | -$3.10 | $0 | |||
| 08/15/2022 | Q2 2022 | -$3.90 | $0 | |||
| 05/16/2022 | Q1 2022 | -$5.35 | $0 | |||
| 03/28/2022 | Q4 2021 | -$0.31 | $0 | |||
| 11/15/2021 | Q3 2021 | -$5.50 | $0 | |||
| 09/27/2021 | Q2 2021 | -$2.84 | $0 | |||
| 03/30/2021 | Q1 2021 | -$4.43 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.05 | $0 | |||
| 09/29/2020 | Q3 2020 | -$1.15 | $0 | |||
| 06/29/2020 | Q2 2020 | -$1.58 | $0 | |||
| 03/30/2020 | Q1 2020 | -$2.73 | $0 |
Dermata Therapeutics, Inc. Earnings: FAQ's
When is Dermata Therapeutics, Inc.'s earnings date?
Dermata Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
How can I listen to Dermata Therapeutics, Inc.'s earnings conference
call?
The conference call for Dermata Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Dermata Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Dermata Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Dermata Therapeutics, Inc. generate each year?
Dermata Therapeutics, Inc. (:DRMAW) has a recorded net income of $0. Dermata Therapeutics, Inc. has generated $-40.18 earnings per share over the last four quarters.
What is Dermata Therapeutics, Inc.'s price-to-earnings ratio?
Dermata Therapeutics, Inc. (:DRMAW) has a price-to-earnings ratio of -0.2 and price/earnings-to-growth ratio is 0.02.